Ummenhofer W C, Arends R H, Shen D D, Bernards C M
Department of Anaesthesia, University of Basel, Kantonsspital, Switzerland.
Anesthesiology. 2000 Mar;92(3):739-53. doi: 10.1097/00000542-200003000-00018.
Despite widespread use, little is known about the comparative pharmacokinetics of intrathecally administered opioids. The present study was designed to characterize the rate and extent of opioid distribution within cerebrospinal fluid, spinal cord, epidural space, and systemic circulation after intrathecal injection.
Equal doses of morphine and alfentanil, fentanyl, or sufentanil were administered intrathecally (L3) to anesthetized pigs. Microdialysis probes were used to sample cerebrospinal fluid at L2, T11, T7, T3, and the epidural space at L2 every 5-10 min for 4 h. At the end of the experiment, spinal cord and epidural fat tissue were sampled, and each probe's recovery was determined in vitro. Using SAAM II pharmacokinetic modeling software (SAAM Institute, University of Washington, Seattle, WA), the data were fit to a 16-compartment model that was divided into four spinal levels, each of which consisted of a caternary arrangement of four compartments representing the spinal cord, cerebrospinal fluid, epidural space, and epidural fat.
Model simulations revealed that the integral exposure (area under the curve divided by dose) of the spinal cord (i.e., effect compartment) to the opioids was highest for morphine because of its low spinal cord distribution volume and slow clearance into plasma The integral exposure of the spinal cord to the other opioids was relatively low, but for different reasons: alfentanil has a high clearance from spinal cord into plasma, fentanyl distributes rapidly into the epidural space and fat, and sufentanil has a high spinal cord volume of distribution.
The four opioids studied demonstrate markedly different pharmacokinetic behavior, which correlates well with their pharmacodynamic behavior.
尽管鞘内注射阿片类药物已被广泛使用,但关于其比较药代动力学的了解却很少。本研究旨在描述鞘内注射后阿片类药物在脑脊液、脊髓、硬膜外间隙和体循环中的分布速率和程度。
将等剂量的吗啡与阿芬太尼、芬太尼或舒芬太尼鞘内注射(L3)给麻醉的猪。使用微透析探针每5 - 10分钟在L2、T11、T7、T3采集脑脊液样本,并在L2硬膜外间隙采集样本,持续4小时。实验结束时,采集脊髓和硬膜外脂肪组织样本,并在体外测定每个探针的回收率。使用SAAM II药代动力学建模软件(华盛顿大学SAAM研究所,西雅图,华盛顿州),将数据拟合到一个16房室模型,该模型分为四个脊髓水平,每个水平由四个房室的四级排列组成,分别代表脊髓、脑脊液、硬膜外间隙和硬膜外脂肪。
模型模拟显示,由于吗啡在脊髓中的分布容积低且向血浆中的清除缓慢,脊髓(即效应室)对吗啡的整体暴露量(曲线下面积除以剂量)最高。脊髓对其他阿片类药物的整体暴露量相对较低,但原因不同:阿芬太尼从脊髓向血浆的清除率高,芬太尼迅速分布到硬膜外间隙和脂肪中,舒芬太尼在脊髓中的分布容积大。
所研究的四种阿片类药物表现出明显不同的药代动力学行为,这与其药效学行为密切相关。